Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Human endogenous retroviruses form a reservoir of T cell targets in hematological cancers.
Saini SK, Ørskov AD, Bjerregaard AM, Unnikrishnan A, Holmberg-Thydén S, Borch A, Jensen KV, Anande G, Bentzen AK, Marquard AM, Tamhane T, Treppendahl MB, Gang AO, Dufva IH, Szallasi Z, Ternette N, Pedersen AG, Eklund AC, Pimanda J, Grønbæk K, Hadrup SR. Saini SK, et al. Among authors: bjerregaard am. Nat Commun. 2020 Nov 9;11(1):5660. doi: 10.1038/s41467-020-19464-8. Nat Commun. 2020. PMID: 33168830 Free PMC article.
MuPeXI: prediction of neo-epitopes from tumor sequencing data.
Bjerregaard AM, Nielsen M, Hadrup SR, Szallasi Z, Eklund AC. Bjerregaard AM, et al. Cancer Immunol Immunother. 2017 Sep;66(9):1123-1130. doi: 10.1007/s00262-017-2001-3. Epub 2017 Apr 20. Cancer Immunol Immunother. 2017. PMID: 28429069 Free PMC article.
Prediction of neoepitopes from murine sequencing data.
Bjerregaard AM, Pedersen TK, Marquard AM, Hadrup SR. Bjerregaard AM, et al. Cancer Immunol Immunother. 2019 Jan;68(1):159-161. doi: 10.1007/s00262-018-2254-5. Epub 2018 Oct 5. Cancer Immunol Immunother. 2019. PMID: 30291365 Free PMC article. No abstract available.
Tumor-Infiltrating T Cells From Clear Cell Renal Cell Carcinoma Patients Recognize Neoepitopes Derived From Point and Frameshift Mutations.
Hansen UK, Ramskov S, Bjerregaard AM, Borch A, Andersen R, Draghi A, Donia M, Bentzen AK, Marquard AM, Szallasi Z, Eklund AC, Svane IM, Hadrup SR. Hansen UK, et al. Among authors: bjerregaard am. Front Immunol. 2020 Mar 12;11:373. doi: 10.3389/fimmu.2020.00373. eCollection 2020. Front Immunol. 2020. PMID: 32226429 Free PMC article.
Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma.
Kristensen NP, Heeke C, Tvingsholm SA, Borch A, Draghi A, Crowther MD, Carri I, Munk KK, Holm JS, Bjerregaard AM, Bentzen AK, Marquard AM, Szallasi Z, McGranahan N, Andersen R, Nielsen M, Jönsson GB, Donia M, Svane IM, Hadrup SR. Kristensen NP, et al. Among authors: bjerregaard am. J Clin Invest. 2022 Jan 18;132(2):e150535. doi: 10.1172/JCI150535. J Clin Invest. 2022. PMID: 34813506 Free PMC article. Clinical Trial.
Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma.
Holm JS, Funt SA, Borch A, Munk KK, Bjerregaard AM, Reading JL, Maher C, Regazzi A, Wong P, Al-Ahmadie H, Iyer G, Tamhane T, Bentzen AK, Herschend NO, De Wolf S, Snyder A, Merghoub T, Wolchok JD, Nielsen M, Rosenberg JE, Bajorin DF, Hadrup SR. Holm JS, et al. Among authors: bjerregaard am. Nat Commun. 2022 Apr 11;13(1):1935. doi: 10.1038/s41467-022-29342-0. Nat Commun. 2022. PMID: 35410325 Free PMC article. Clinical Trial.
Neoantigen reactive T cells correlate with the low mutational burden in hematological malignancies.
Saini SK, Holmberg-Thydén S, Bjerregaard AM, Unnikrishnan A, Dorfmüller S, Platzbecker U, Tirado-Gonzalez I, Bönig H, El Fassi D, Grønbæk K, Pimanda J, Medyouf H, Hadrup SR. Saini SK, et al. Among authors: bjerregaard am. Leukemia. 2022 Nov;36(11):2734-2738. doi: 10.1038/s41375-022-01705-y. Epub 2022 Oct 8. Leukemia. 2022. PMID: 36209321 Free PMC article. No abstract available.
13 results